BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Earnings

  Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations

  With the commercial business performing so well, Eli Lilly is eyeing earlier business development bets to build out a longer-term pipeline.

  October 29, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Utah Medical Products, Inc. Reports Corrected Results of Tender Offer

  October 29, 2026

   · 

  1 min read
• Press Releases

  Laplace Interventional™ Announces First Patients treated in TRIUMPH Pivotal Trial with its Transcatheter Tricuspid Valve Replacement System

  October 29, 2026

   · 

  2 min read
• 

  Drug Development

  Dren Bio lands $350M to push rare blood cancer therapy toward market

  After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead asset.

  October 29, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• Press Releases

  iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent

  October 29, 2026

   · 

  4 min read